Tools · Private company · Northampton, MA, US
Latde Diagnostics Corp.
Track this companyFree. Adds Latde Diagnostics Corp. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Rapid lateral flow-based antibiotic susceptibility testing for urinary tract infectionsFiscal year 2025 · $272.2KNIH RePORTER 5R43AI186702-02 · fetched Nov 12, 2026
- Rapid, equitable, lateral flow-based antibiotic susceptibility testing for urinary tract infectionsFiscal year 2024 · $299.2KNIH RePORTER 1R43AI186702-01 · fetched Nov 12, 2026